Literature DB >> 31827242

Familial myeloid malignancies with germline TET2 mutation.

Nicolas Duployez1,2, Laure Goursaud3, Laurène Fenwarth4,5, Claire Bories6, Alice Marceau-Renaut4,5, Thomas Boyer4,5, Elise Fournier4,7, Olivier Nibourel4,5, Catherine Roche-Lestienne5,8, Guillemette Huet5,9, David Beauvais3, Céline Berthon5,3, Nathalie Cambier3,10, Bruno Quesnel5,3, Claude Preudhomme4,5.   

Abstract

Entities:  

Year:  2019        PMID: 31827242     DOI: 10.1038/s41375-019-0675-6

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  Germline Abnormalities in DNA Methylation and Histone Modification and Associated Cancer Risk.

Authors:  Jenna A Fernandez; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2022-06-02       Impact factor: 4.213

2.  Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.

Authors:  Sushree S Sahoo; Victor B Pastor; Charnise Goodings; Rebecca K Voss; Emilia J Kozyra; Amina Szvetnik; Peter Noellke; Michael Dworzak; Jan Starý; Franco Locatelli; Riccardo Masetti; Markus Schmugge; Barbara De Moerloose; Albert Catala; Krisztián Kállay; Dominik Turkiewicz; Henrik Hasle; Jochen Buechner; Kirsi Jahnukainen; Marek Ussowicz; Sophia Polychronopoulou; Owen P Smith; Oksana Fabri; Shlomit Barzilai; Valerie de Haas; Irith Baumann; Stephan Schwarz-Furlan; Marena R Niewisch; Martin G Sauer; Birgit Burkhardt; Peter Lang; Peter Bader; Rita Beier; Ingo Müller; Michael H Albert; Roland Meisel; Ansgar Schulz; Gunnar Cario; Pritam K Panda; Julius Wehrle; Shinsuke Hirabayashi; Marta Derecka; Robert Durruthy-Durruthy; Gudrun Göhring; Ayami Yoshimi-Noellke; Manching Ku; Dirk Lebrecht; Miriam Erlacher; Christian Flotho; Brigitte Strahm; Charlotte M Niemeyer; Marcin W Wlodarski
Journal:  Nat Med       Date:  2021-10-07       Impact factor: 87.241

Review 3.  TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.

Authors:  Yihong Guan; Metis Hasipek; Anand D Tiwari; Jaroslaw P Maciejewski; Babal K Jha
Journal:  Semin Hematol       Date:  2020-12-28       Impact factor: 3.851

Review 4.  Germline risk of clonal haematopoiesis.

Authors:  Alexander J Silver; Alexander G Bick; Michael R Savona
Journal:  Nat Rev Genet       Date:  2021-05-13       Impact factor: 53.242

5.  Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: The NHLBI TOPMed program.

Authors:  Anna V Mikhaylova; Caitlin P McHugh; Linda M Polfus; Laura M Raffield; Meher Preethi Boorgula; Thomas W Blackwell; Jennifer A Brody; Jai Broome; Nathalie Chami; Ming-Huei Chen; Matthew P Conomos; Corey Cox; Joanne E Curran; Michelle Daya; Lynette Ekunwe; David C Glahn; Nancy Heard-Costa; Heather M Highland; Brian D Hobbs; Yann Ilboudo; Deepti Jain; Leslie A Lange; Tyne W Miller-Fleming; Nancy Min; Jee-Young Moon; Michael H Preuss; Jonathon Rosen; Kathleen Ryan; Albert V Smith; Quan Sun; Praveen Surendran; Paul S de Vries; Klaudia Walter; Zhe Wang; Marsha Wheeler; Lisa R Yanek; Xue Zhong; Goncalo R Abecasis; Laura Almasy; Kathleen C Barnes; Terri H Beaty; Lewis C Becker; John Blangero; Eric Boerwinkle; Adam S Butterworth; Sameer Chavan; Michael H Cho; Hélène Choquet; Adolfo Correa; Nancy Cox; Dawn L DeMeo; Nauder Faraday; Myriam Fornage; Robert E Gerszten; Lifang Hou; Andrew D Johnson; Eric Jorgenson; Robert Kaplan; Charles Kooperberg; Kousik Kundu; Cecelia A Laurie; Guillaume Lettre; Joshua P Lewis; Bingshan Li; Yun Li; Donald M Lloyd-Jones; Ruth J F Loos; Ani Manichaikul; Deborah A Meyers; Braxton D Mitchell; Alanna C Morrison; Debby Ngo; Deborah A Nickerson; Suraj Nongmaithem; Kari E North; Jeffrey R O'Connell; Victor E Ortega; Nathan Pankratz; James A Perry; Bruce M Psaty; Stephen S Rich; Nicole Soranzo; Jerome I Rotter; Edwin K Silverman; Nicholas L Smith; Hua Tang; Russell P Tracy; Timothy A Thornton; Ramachandran S Vasan; Joe Zein; Rasika A Mathias; Alexander P Reiner; Paul L Auer
Journal:  Am J Hum Genet       Date:  2021-09-27       Impact factor: 11.043

Review 6.  Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.

Authors:  Sushree S Sahoo; Emilia J Kozyra; Marcin W Wlodarski
Journal:  Best Pract Res Clin Haematol       Date:  2020-07-29       Impact factor: 3.020

7.  Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.

Authors:  Sara Mellid; Javier Coloma; Bruna Calsina; María Monteagudo; Juan M Roldán-Romero; María Santos; Luis J Leandro-García; Javier Lanillos; Ángel M Martínez-Montes; Cristina Rodríguez-Antona; Cristina Montero-Conde; Joaquín Martínez-López; Rosa Ayala; Xavier Matias-Guiu; Mercedes Robledo; Alberto Cascón
Journal:  Cancers (Basel)       Date:  2020-11-09       Impact factor: 6.639

8.  TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan.

Authors:  Abdul Rehman Khalil Shaikh; Ikram Ujjan; Muhammad Irfan; Arshi Naz; Tahir Shamsi; Muhammad Tariq Masood Khan; Muhammad Shakeel
Journal:  PeerJ       Date:  2021-02-09       Impact factor: 2.984

Review 9.  Age-Associated TET2 Mutations: Common Drivers of Myeloid Dysfunction, Cancer and Cardiovascular Disease.

Authors:  Christina K Ferrone; Mackenzie Blydt-Hansen; Michael J Rauh
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

10.  The epigenetic pioneer EGR2 initiates DNA demethylation in differentiating monocytes at both stable and transient binding sites.

Authors:  Karina Mendes; Sandra Schmidhofer; Julia Minderjahn; Dagmar Glatz; Claudia Kiesewetter; Johanna Raithel; Julia Wimmer; Claudia Gebhard; Michael Rehli
Journal:  Nat Commun       Date:  2021-03-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.